- Home
- MOGU vs SNTI Comparison
MOGU vs SNTI Comparison
Compare MOGU & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOGU
- SNTI
- Stock Information
- Founded
- MOGU 2011
- SNTI 2016
- Country
- MOGU China
- SNTI United States
- Employees
- MOGU N/A
- SNTI N/A
- Industry
- MOGU Business Services
- SNTI Biotechnology: Pharmaceutical Preparations
- Sector
- MOGU Consumer Discretionary
- SNTI Health Care
- Exchange
- MOGU Nasdaq
- SNTI Nasdaq
- Market Cap
- MOGU 19.8M
- SNTI 39.6M
- IPO Year
- MOGU 2018
- SNTI N/A
- Fundamental
- Price
- MOGU $4.73
- SNTI $1.36
- Analyst Decision
- MOGU
- SNTI Strong Buy
- Analyst Count
- MOGU 0
- SNTI 2
- Target Price
- MOGU N/A
- SNTI $8.50
- AVG Volume (30 Days)
- MOGU 3.6M
- SNTI 123.0K
- Earning Date
- MOGU 07-21-2025
- SNTI 11-13-2025
- Dividend Yield
- MOGU N/A
- SNTI N/A
- EPS Growth
- MOGU N/A
- SNTI N/A
- EPS
- MOGU N/A
- SNTI N/A
- Revenue
- MOGU $19,462,964.00
- SNTI N/A
- Revenue This Year
- MOGU N/A
- SNTI N/A
- Revenue Next Year
- MOGU N/A
- SNTI $150.00
- P/E Ratio
- MOGU N/A
- SNTI N/A
- Revenue Growth
- MOGU N/A
- SNTI N/A
- 52 Week Low
- MOGU $1.83
- SNTI $1.26
- 52 Week High
- MOGU $8.10
- SNTI $16.94
- Technical
- Relative Strength Index (RSI)
- MOGU 86.11
- SNTI 34.87
- Support Level
- MOGU $2.41
- SNTI $1.38
- Resistance Level
- MOGU $8.10
- SNTI $1.39
- Average True Range (ATR)
- MOGU 0.47
- SNTI 0.08
- MACD
- MOGU 0.28
- SNTI 0.01
- Stochastic Oscillator
- MOGU 43.75
- SNTI 28.57
About MOGU MOGU Inc.
MOGU Inc is an online service provider in China, operating a KOL-driven online fashion and lifestyle platform, Mogujie, and providing customized online branding solutions to businesses. The company, on its platform, provides content related to fashion and lifestyle guides in various multimedia formats, which include Live Video Broadcasts, Short-form Videos, Photography, and an Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology, and other relevant services to merchants and users, as well as technology services to brand owners.
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.